Top Markets
Coin of the day
Metsera, Inc. Metsera, Inc.

Metsera, Inc.

MTSR
Hisse Senetlerindeki Sıralama #2736
Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in... Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in crafting both injectable and oral nutrient-stimulated hormone analog peptides. These therapeutic compounds are primarily aimed at addressing obesity, overweight conditions, and associated health issues. Its developmental pipeline features MET-097i and MET-233i, both under investigation for treating obesity and overweight patients. Furthermore, Metsera is advancing a potential combination therapy involving MET-233i and MET-097i. The company is also progressing additional drug candidates, including MET-002, MET-224o, MET-067i, and MET-034i, all of which target disorders such as diabetes and obesity. Founded in 2022, Metsera, Inc. maintains its corporate headquarters in New York, New York.
Hisse Fiyatı
$70.50
Son senkronizasyon: 2025-11-14
Piyasa Değeri
$7.33B
Değişim (1 gün)
0.00%
Değişim (1 yıl)
116.32%
Ülke
US
Ticaret Metsera, Inc. (MTSR)

Kategori

Metsera, Inc. (MTSR) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $72.34 - 2025-11-01

Gün sonu en düşük fiyat: $26.50 - 2025-01-01
Metsera, Inc. için hisse fiyatı geçmişi: 2025 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -29.98%
2025 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$553.09 42.20%
US
$1.02K 50.56%
NL
$158.64 525.80%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH